DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Anamorelin is an investigational drug.
There have been 11 clinical trials for Anamorelin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, and Cachexia. The leading clinical trial sponsors are Helsinn Therapeutics (U.S.), Inc, Helsinn Healthcare SA, and M.D. Anderson Cancer Center.
There are sixty-four US patents protecting this investigational drug and six hundred and fifty-three international patents.
Recent Clinical Trials for Anamorelin
|Anamorelin Study for Advanced Pancreatic Cancer||Helsinn Healthcare SA||Phase 2|
|Anamorelin Study for Advanced Pancreatic Cancer||Quartesian LLC||Phase 2|
|Anamorelin Study for Advanced Pancreatic Cancer||Lahey Clinic||Phase 2|
Top disease conditions for Anamorelin
Top clinical trial sponsors for Anamorelin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Anamorelin||Try Before You Buy||Antidiabetic compounds||Merck Sharp & Dohme Corp. (Rahway, NJ)||Try Before You Buy|
|Anamorelin||Try Before You Buy||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Try Before You Buy|
|Anamorelin||Try Before You Buy||Binding proteins and methods of use thereof||NGM Biopharmaceuticals, Inc. (South San Francisco, CA)||Try Before You Buy|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Anamorelin||European Patent Office||EP3102198||2034-02-06||Try Before You Buy|
|Anamorelin||World Intellectual Property Organization (WIPO)||WO2015119899||2034-02-06||Try Before You Buy|
|Anamorelin||Australia||AU2017261372||2036-05-05||Try Before You Buy|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|